Tag - medicine

 
Menu
Search
 
April 18, 2025
 

Today's print edition

Home Delivery
Subscribe for more access

MEDICINE

Japan Times
WORLD / Science & Health
Nov 16, 2021
Pfizer to allow generic versions of its COVID-19 pill in 95 countries
A Pfizer executive said last week the market for the drug might be up to 150 million people and that many countries might also be interested in buying doses for their strategic reserves.
JAPAN
Nov 13, 2021
COVID cases in Tokyo hit 471,000 as of March — quadruple official tally — study says
Researchers say asymptomatic or mild cases likely behind dramatic undercount in number of coronavirus infections.
Japan Times
COMMENTARY / World
Nov 12, 2021
Why COVID-19 misinformation works
Misinformed people, especially about COVID-19, do not simply have inaccurate information; they are heavily invested in their misconceptions.
Japan Times
WORLD
Nov 9, 2021
Regeneron antibody prevents COVID-19 infections for eight months
The company has asked the U.S. Food and Drug Administration to expand the authorization so the drug can be used to prevent infections.
Japan Times
WORLD / ANALYSIS
Nov 9, 2021
COVID-19 pills no substitute for vaccines, disease experts say
Some experts fear the arrival of oral treatments for the coronavirus may further impede vaccination campaigns.
Japan Times
ASIA PACIFIC
Nov 8, 2021
South Korea to purchase 70,000 courses of new Pfizer COVID-19 pill
Pfizer has said trial results showed that its Paxlovid pill reduced by 89% the risk of hospitalization or death in some patients.
Japan Times
COMMENTARY / World
Nov 7, 2021
COVID-19 drugs will change the way we live with the virus
New COVID-19 drug approvals couldn't be timelier as hospitals face massive backlogs of delayed procedures.
Japan Times
WORLD / Science & Health / ANALYSIS
Nov 6, 2021
Pfizer results open door to new chapter for COVID treatments
The world needs an easy-to-take COVID-19 treatment. Pfizer Inc.'s and Merck & Co. Inc.'s new pills may be just that. But questions remain about their safety and how well they will work.
Japan Times
WORLD / Science & Health
Nov 5, 2021
Pfizer develops COVID-19 pill that cuts hospitalizations and deaths by 89%
The drugmaker claims 'overwhelming efficacy” and plans to submit their findings for emergency authorization as soon as possible.
Japan Times
COMMENTARY / World
Nov 5, 2021
Lessons ASEAN could learn from Malaysia’s pandemic success
Malaysia has fully vaccinated more than 77% its population, with some 90% of adults — those deemed eligible for the vaccine — receiving a second dose.
Japan Times
COMMENTARY
Nov 3, 2021
Post-pandemic recovery must include the unpaid care economy
The unpaid care sector for the most part remains unaccounted for in standard government policy tools and its work is primarily performed by women.
Japan Times
WORLD / Science & Health
Nov 2, 2021
How often do COVID-19 vaccines cause heart problems in kids?
While the vaccines made by Pfizer-BioNTech and Moderna do seem to be associated with an increased risk of myocarditis, the absolute risk remains very small.
Japan Times
WORLD
Oct 30, 2021
Pfizer won the first round, but Moderna sees final victory ahead
Pfizer has been first across the finish line in nearly every leg of the COVID-19 vaccine race, but Moderna executives say their company's mRNA technology gives it an advantage.
Japan Times
COMMENTARY / World
Oct 24, 2021
The overlooked victims of COVID-19: The children
The isolation measures imposed by the pandemic have severely curtailed social development in children, resulting in a wide array of mental, emotional and behavioral health issues.
Japan Times
COMMENTARY / World
Oct 24, 2021
A dangerous global divide on vaccine access
The inequitable vaccine divide leaves humanity far more vulnerable to the next stage of the pandemic, as well as to any other systemic crisis that may emerge.
Japan Times
WORLD
Oct 23, 2021
Benefits of Pfizer child shot likely outweigh risks, FDA says
Clearing a vaccine for elementary-school age children would mark a major milestone in the pandemic.
JAPAN / Explainer
Oct 20, 2021
Oral drug molnupiravir seen as 'trump card' in Japan's battle against COVID-19
The treatment developed by Merck could receive fast-track approval by the end of the year, and other oral drugs to fight the coronavirus are not far behind.
Japan Times
WORLD / Science & Health
Oct 19, 2021
What scientists know about the risk of breakthrough COVID-19 deaths
After former U.S. Secretary of State Colin Powell died Monday from COVID-19 complications, vaccine skeptics immediately seized on news that he had been vaccinated to stoke doubts.
Japan Times
WORLD
Oct 15, 2021
U.S. FDA advisers back Moderna COVID-19 booster shots for older and high-risk people
If the FDA signs off on Moderna's booster, the U.S. Centers for Disease Control and Prevention will make specific recommendations on who should get the shots.
Japan Times
WORLD
Oct 14, 2021
Rush to buy Merck’s COVID-19 pill risks leaving poor countries behind
Despite efforts to license molnupiravir to generic-drug firms, the same risks of unequal distribution remain, says report.
In a first, Japan issues cease-and-desist order against Google
The Google logo is seen at the company's Bay View campus in Mountain View, California. Japanese authorities on Tuesday issued a cease-and-desist order to Google over an alleged violation of the country's anti-monopoly law.
Japan and the U.S. begin tariff talks on good terms, but without breakthroughs
Ryosei Akazawa, Japan's chief tariff negotiator, speaks to reporters in Washington on Wednesday.
Trump calls the U.S.-Japan alliance ‘one-sided.’ Tokyo says otherwise.
U.S. President Donald Trump speaks during a Cabinet meeting at the White House on Thursday in Washington.
Tokyo hotel operators face possible warnings over suspected price cartel
Foreign tourists gather on a platform at Kyoto Station on Wednesday.
China executes man over Japanese school bus stop murder
The bus stop in Suzhou, Jiangsu Province, China, where a Japanese mother, her child, and a Chinese woman were attacked in June 2024
Tokyo hotel operators face possible warnings over suspected price cartel
Foreign tourists gather on a platform at Kyoto Station on Wednesday.
Kyotographie 2025 opts for laughter and levity in the face of global strife
Palestinian American photographer Adam Rouhana’s exhibition at this year’s Kyotographie festival shows Palestinian life, not death and rubble.
Privacy and transparency clash in debate over bill on artificial insemination
Sachiko Ishizuka, who was born via artificial insemination by donor (AID), tells her story to lawmakers from the Constitutional Democratic Party of Japan on April 9.
Why Ishiba became the first prime minister to hold talks with Rengo in 16 years
Prime Minister Shigeru Ishiba and Japanese Trade Union Confederation chief Tomoko Yoshino in a meeting Tuesday at the Prime Minister's Office
In a first, Japan issues cease-and-desist order against Google
The Google logo is seen at the company's Bay View campus in Mountain View, California. Japanese authorities on Tuesday issued a cease-and-desist order to Google over an alleged violation of the country's anti-monopoly law.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo’s Shinjuku Ward.
Kabukicho: Tokyo’s ‘stadium of desire’

Longform

Visitors walk past Sou Fujimoto's Grand Ring, which has been recognized as the largest wooden structure in the world.
Can a World Expo still matter? Japan is about to find out.
By Tomoko Otake

SUSTAINABLE JAPAN

BOARDING & INTERNATIONAL SCHOOL DAY 2025 (Sunday, April 20)
BOARDING & INTERNATIONAL SCHOOL DAY 2025 (Sunday, April 20)

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER